Acosta, E., Gagnon A., Ouellette N., Bourbeau R., Nepomuceno M., and van Raalte A. A.
(2020). The boomer penalty: Excess mortality among baby boomers in Canada and the United States.
MPIDR Working Paper, Rostock, DE: Max Planck Institute for Demographic Research (MPIDR). Abstract |
Hajizadeh, M., and Edmonds S.
(2020). Universal pharmacare in Canada: A prescription for equity in healthcare.
International Journal of Health Policy and Management, 9 (3), 91-95. Abstract |
St-Amour, S., Hains-Monfette G., Dancause K. N., Cailhol L., and Bernard P.
(2020). Antidepressant medication use and objectively measured physical activity and sedentary behaviors in adults: A cross-sectional analysis of nationally representative sample of Canadian adults.
SportrXiv Preprints, 1-16.: SportrXiv. Abstract |
Patten, S. B., and Williams J. V. A.
(2020). Lithium, an infrequently used medication.
Canadian Journal of Psychiatry, 65 (3), 204-205. Abstract |
Guo, E. Xiaoyu, Sweetman A., and G. Guindon E.
(2020). Socioeconomic differences in prescription drug supplemental coverage in Canada: A repeated cross-sectional study.
Health Policy, 124 (3), 252-260. Abstract |
Men, F., Gundersen C., Urquia M. L., and Tarasuk V.
(2019). Prescription medication nonadherence associated with food insecurity: A population-based cross-sectional study.
CMAJ Open, 7 (3), E590-E597. Abstract |
Chao, Y-S., Wu C-J., Wu H-C., and Chen W-C.
(2019). Drug trends among non-institutionalized Canadians and the impact of data collection changes in the Canadian Health Measures Survey 2007 to 2015.
PlosONE, 14 (4), 1-17. Abstract |
Chan, F. K. I., McGrail K., Majumdar S. R., and Law M. R.
(2019). Changes in employer-sponsored private health insurance among retirees in Ontario: a cross-sectional study.
CMAJ Open, 7 (1), E15-E22. Abstract |
Amoud, R.
(2018). The impact of prescription medication cost coverage on optimal adherence to Hypertension and Diabetes Mellitus oral medications.
School of Pharmacy. Waterloo, ON: University of Waterloo. Abstract |
Cohen, S., Liu A., Guo L., and Marelli A. J.
(2018). The burden of breast cancer in adult women with congenital heart disease.
Archives of Cardiovascular Diseases Supplements, 10 (1), 142. Abstract |
Law, M. R., Cheng L., Kolhatkar A., Goldsmith L. J., Morgan S. G., Holbrook A. M., et al.
(2018). The consequences of patient charges for prescription drugs in Canada: A cross-sectional survey.
CMAJ Open, 6 (1), E63-E70. Abstract |
Kolhatkar, A., Cheng L., Morgan S. G., Goldsmith L. J., Dhalla I. A., Holbrook A. M., et al.
(2018). Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: A descriptive analysis.
CMAJOpen, 6 (4), E554-E550. Abstract |
Woolf, B. A. R., Williams J. V. A., Lavorato D. H., Bulloch A. G. M., and Patten S. B.
(2017). A comparison of recommendations and received treatment for mood and anxiety disorders in a representative national sample.
BMC Psychiatry, 17 (155), 1-11. Abstract |
Chan, F. K. I.
(2017). An examination of influences on prescription drug use amongst older adults with and without chronic illness in two Canadian provinces.
School of Population and Public Health. Vancouver, BC: University of British Columbia. Abstract |
Clair, L.
(2017). Private supplemental insurance and mental health care utilization in Canada: An investigation using nonparametric estimation methods.
: Memorial University of Newfoundland. Abstract |
Hirsch, L. E.
(2016). Second-generation antipsychotics and metabolic side effects in the Canadian population.
Calgary, AB: University of Calgary. Abstract |
Rubinato, T.
(2016). The effect of public insurance on the use of prescription drugs: A cross-province analysis among seniors with chronic conditions.
Department of Economics. Montréal, QC: McGill University. Abstract |
Mudryj, A. N., de Groh M., Aukema H. M., and Yu N.
(2016). Folate intakes from diet and supplements may place certain Canadians at risk for folic acid toxicity.
British Journal of Nutrition, 116 (7), 1236-1245. Abstract |
Kratzer, J., Cheng L., Allin S., and Law M. R.
(2015). The impact of private insurance coverage on prescription drug use in Ontario, Canada.
Healthcare Policy, 10 (4), 62-74. Abstract |
Wang, C., Li Q., Sweetman A., and Hurley J.
(2015). Mandatory universal drug plan, access to health care and health: Evidence from Canada.
Journal of Health Economics, 44 (December), 80-96. Abstract |
Munasinghe, L. L., Willows N., Yuan Y., and Veugelers P. J.
(2015). The prevalence and determinants of use of vitamin D supplements among children in Alberta, Canada: A cross-sectional study.
BMC Public Health, 15 (1), 1-7. Abstract |
Roach, S.
(2014). The impact of prescription drug insurance on healthcare utilization.
Department of Economics. Ottawa, ON: University of Ottawa. Abstract |
Breau, S.
(2014). Inégalité des revenus au Canada: Une analyse régionale.
(Breau, S., Ed.),{Nouvelles perspectives en développement régional: Essais en l'honneur de Donald J. Savoie}, 95-123.: Presses de l'Universite du Quebec. |
Saadé, S., and Marchand A.
(2013). Work organization conditions and prescribed psychotropic drug use in Canada: The moderating role of personality traits.
Journal of Workplace Behavioral Health, 28 (1), 62-80. Abstract |
Votova, K. M. E., Blais R., Penning M. J., and MacLure M. K.
(2013). Polypharmacy meets polyherbacy: Pharmaceutical, over-the-counter, and natural health product use among Canadian adults.
Canadian Journal of Public Health, 104 (3), e222-e228. Abstract |